Replimune (REPL) Payables (2018 - 2026)
Replimune (REPL) recorded Payables of $4.26 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 72.5% from $15.48 million a year earlier and down 36.1% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Payables (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Replimune reported Payables of $6.67 million, down 46.5% from FY2025.
- Annual Payables has a five-year compound annual growth rate of 23.2% (FY2021 to FY2026).
- Across earlier fiscal years, Payables came in at $12.46 million in FY2025 (+383.4%), $2.58 million in FY2024 (-51.9%), $5.36 million in FY2023 (+43.7%) and $3.73 million in FY2022 (+58.5%).
- The fiscal Q1 2027 figure is the lowest quarterly Payables since fiscal Q1 2025.
- On a year-over-year basis, Payables has declined for four consecutive quarters, with growth averaging 56.6% over the last seven quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 383.4% in fiscal Q4 2025, against a decline of 82.3% in fiscal Q1 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $6.67 million (Q4 2026), $5.65 million (Q3 2026) and $6.4 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Replimune | 1.05 Bn | 1.05 Bn | - | 4.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.26 Mn |
| Mar 31, 2026 | 6.67 Mn |
| Dec 31, 2025 | 5.65 Mn |
| Sep 30, 2025 | 6.40 Mn |
| Jun 30, 2025 | 15.48 Mn |
| Mar 31, 2025 | 12.46 Mn |
| Dec 31, 2024 | 7.19 Mn |
| Sep 30, 2024 | 8.41 Mn |
| Jun 30, 2024 | 864,000.00 |
| Mar 31, 2024 | 2.58 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Sep 30, 2023 | 4.37 Mn |
| Jun 30, 2023 | 4.88 Mn |
| Mar 31, 2023 | 5.36 Mn |
| Dec 31, 2022 | 3.65 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Jun 30, 2022 | 4.48 Mn |
| Mar 31, 2022 | 3.73 Mn |
| Dec 31, 2021 | 3.92 Mn |
| Sep 30, 2021 | 3.15 Mn |
API Access
Replimune Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();